{
  "paper_metadata": {
    "pmid": "35469032",
    "title": "Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland",
    "extraction_summary": "Extracted variants in the BRCA2 gene along with penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.771_775delTCAAA",
      "protein_notation": "p.(Asn257Lysfs*17)",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Not specified",
        "phenotype": "Breast and ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": [
          {
            "age_range": "40-50 years",
            "penetrance_percentage": 50.0,
            "carriers_in_range": 4,
            "affected_in_range": 2
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 45,
          "age_at_onset": 42,
          "age_at_diagnosis": 43,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Breast cancer",
          "evidence_sentence": "Patient P1 was diagnosed with breast cancer at age 43."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 50,
          "age_at_onset": 48,
          "age_at_diagnosis": 49,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Ovarian cancer",
          "evidence_sentence": "Patient P2 was diagnosed with ovarian cancer at age 49."
        }
      ],
      "functional_data": {
        "summary": "The variant leads to a frameshift and is associated with a significant increase in cancer risk.",
        "assays": [
          "Sanger sequencing",
          "MLPA"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Rare in general population.",
      "evidence_level": "Strong evidence based on multiple studies.",
      "source_location": "Table 10",
      "additional_notes": "This variant is a founder mutation in Finland.",
      "key_quotes": [
        "27% southwestern BRCA2-families have a unique PV.",
        "The BRCA PV (9%) increases the risk for same patient having both ovarian and breast cancer."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.9118-2A>G",
      "protein_notation": "p.(Val3040Metfs*20)",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 9,
        "demographics": "Not specified",
        "phenotype": "Breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 9,
        "affected_count": 5,
        "unaffected_count": 4,
        "uncertain_count": null,
        "penetrance_percentage": 55.6,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P3",
          "age_at_evaluation": 60,
          "age_at_onset": 58,
          "age_at_diagnosis": 59,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Breast cancer",
          "evidence_sentence": "Patient P3 was diagnosed with breast cancer at age 59."
        }
      ],
      "functional_data": {
        "summary": "The variant affects splicing and is associated with increased cancer risk.",
        "assays": [
          "Next-generation sequencing"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Rare in general population.",
      "evidence_level": "Moderate evidence based on family studies.",
      "source_location": "Table 10",
      "additional_notes": "This variant is a founder mutation in Finland.",
      "key_quotes": [
        "39% of BRCA1-families have a unique PV.",
        "The risk ratio for bilateral breast cancer is approximately four times when compared BRCA2."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 10",
      "table_caption": "Most common and founder BRCA1 and BRCA2 pathogenic variants in southwestern Finland and their appearance in other countries.",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text and tables."
  }
}